proline and maraviroc

proline has been researched along with maraviroc in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Binet, L; Djerada, Z; Feliu, C; Gozalo, C; Lamiable, D; Marty, H; Millart, H; Robinet, A; Tournois, C; Vautier, D1
Fang, A; Heera, J; Kantaridis, C; Plotka, A; Vourvahis, M1
AlAjmi, MF; Anwar, S; Hassan, MI; Hussain, A; Islam, A; Mohammad, T; Rehman, MT; Shamsi, A1

Trials

1 trial(s) available for proline and maraviroc

ArticleYear
The effects of boceprevir and telaprevir on the pharmacokinetics of maraviroc: an open-label, fixed-sequence study in healthy volunteers.
    Journal of acquired immune deficiency syndromes (1999), 2014, Apr-15, Volume: 65, Issue:5

    Topics: Adolescent; Adult; Antiviral Agents; Cyclohexanes; Healthy Volunteers; Humans; Male; Maraviroc; Middle Aged; Oligopeptides; Proline; Triazoles; Young Adult

2014

Other Studies

2 other study(ies) available for proline and maraviroc

ArticleYear
Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
    Journal of pharmaceutical and biomedical analysis, 2013, Volume: 86

    Topics: Adenine; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Maraviroc; Mass Spectrometry; Nitriles; Organophosphonates; Proline; Pyridazines; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tandem Mass Spectrometry; Tenofovir; Time Factors; Triazoles

2013
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.
    Bioscience reports, 2020, 06-26, Volume: 40, Issue:6

    Topics: Aminoisobutyric Acids; Antiviral Agents; Betacoronavirus; Computer Simulation; Cyclopropanes; Drug Evaluation, Preclinical; Lactams, Macrocyclic; Leucine; Maraviroc; Molecular Structure; Proline; Protease Inhibitors; Quinoxalines; SARS-CoV-2; Sulfonamides

2020